ADURS Logo
myADURS  |  Sitemap  |  Contact Us 
 American Drug Utilization Review Society  
Welcome to ADURS.com

Elgene Jacobs, Ph.D. Elgene Jacobs, Ph.D.
Executive Director
E-mail: Elgene-Jacobs@ouhsc.edu
Kristen Jacobs Kristen Jacobs
Administrative Assistant
E-mail: adurs.inc@gmail.com

Industry News

CONTACTING ADURS STAFF: ADURS is staffed on a volunteer/parttime basis. We will make every attempt to respond to your question or concern within 5 to 7 working days.

Have news to share? Click here to submit.



Announcement

ADURS 2010 email this announcement  print view this announcement
The ADURS2010 Annualy Symposium will be held at the Doubletree-Paradise-Valley-Resort in Scottsdale, Arizona on February 25-Feruary 28, 2010. A preliminary agenda of the Symposium will be posted here in September 2009.


ADURS 2009 Annual Symposium email this announcement  print view this announcement
The ADURS2009 Annualy Symposium will be held at the Doubletree-Paradise-Valley-Resort in Scottsdale, Arizona on February 26-March 1, 2009. A preliminary agenda of the Symposium will be posted here in September.


CMS REPORT FORM email this announcement  print view this announcement
The CMS report form is posted under the "archives" tab.


ADURS2008 email this announcement  print view this announcement
The ADURS2008 program materials are now posted under the "archives" tab.


 

myADURS (For Members Only)

Participate in discussion forum
Retrieve member's contact information
Update personal information

Registered members enter below to gain access:
Login Name  
Password  
 
Forgot Your Login Name or Password?

Register to access myADURS

Note: To obtain registration and access to "myADURS", an individual must be active in a State DUR program; and the designated DUR person from that State must verify the applicant’s participation in State DUR and recommend the applicant to ADURS.

Note: Individual login information is non-transferable. To prevent illegitimate uses, all login activities will be recorded and monitored.


© 2006 American Drug Utilization Review Society, Inc
Questions, comments, suggestions? E-mail: ADURS.INC@gmail.com | Disclaimer
ElementFusion.